Author (reference) | Acute Use | Preventive use | Pulses per dose | Seconds of stimulation | Stimulation intervals | Stimulation frequency | Total seconds | Location |
---|---|---|---|---|---|---|---|---|
Nesbitt et al (52) | Yes | NR | NR | NR | NR | NR | NR | NR |
Eren et al (53) | Three pulses acutely | Morning and evening | 3 | 90 | NR | 2 | 540/24 h + acute | Left |
Tso et al (51) | NR | Yes | 2–4 | 120 | NR | 2–3 (twice if 4 stimulations) | 480–1,080/24 h | Ipsilateral to headache |
Trimboli et al (49) | Three consecutive doses | Three times a day | 2 | 90 | Consecutive | 3 | 540/24 + acute | Either one side or bilateral |
Kamourieh et al (54) | No | Three times a day | 2 | 120 | Consecutive | 3 | 720/24 h | Ipsilateral to headache |
Moreno-Ajona et al (55) | No | Three times a day | 2 | 120 | Consecutive | 3 | 720/24 h | Bilateral |
Aa, amplitude adjustment; CCH, chronic cluster headache; CM, chronic migraine; CPH, chronic paroxysmal hemicrania; DC, direct current; HC, hemicrania continua; MC, muscle contraction; NA, not applicable; NR, not reported; PCH, primary cough headache; RTT, refractory to treatment